Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2476-2486
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2476
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2476
Table 3 Alpha-fetoprotein efficacy evaluation
| Group | AFP before treatment | AFP after treatment | Z | P value |
| DEB-TACE group in ng/mL | 275.1 (17.2-5428.8) | 41.7 (4.7-619.7) | -3.810 | < 0.001 |
| Group A in ng/mL | 155.9 (11.9, 1386.6) | 26.5 (4.6, 200.6) | -2.793 | 0.005 |
| Group B in ng/mL | 5428.8 (33.5, 20000) | 459.9 (4.6, 7670.5) | -2.341 | 0.019 |
- Citation: Ye ZD, Zhuang L, Song MC, Yang Z, Zhang W, Zhang JF, Cao GH. Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2476-2486
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2476.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2476